Health officials find first cases of new superbug in US
(By Sharon Begley for STAT) Just five months after federal health officials asked hospitals and physicians to be on the
Read More
Part D/Prescription Drugs
What clinical trial results? Now you can see who isn’t sharing their findings
(By Ed Silverman for STAT) The results for nearly half of all clinical trials conducted by big drug makers during
Read MoreShopping Guide for Medicare Part D Plans
In Philip Moeller’s column “Ask Phil” for PBS Newshour, he reviews the basics of the Medicare Part D benefit and
Read MoreHospitals are itching for a share of the Mylan settlement over Medicaid rebates
(By Ed Silverman for STAT) More than 1,200 hospitals around the country want to know if they were overcharged by
Read MoreThe backlash over high drug prices is hitting pharma where it hurts
(By Meghana Keshavan for STAT) The simmering public outrage over drug prices finally seems to be catching up to the
Read MoreHow Do We Lower Medicare Drug Costs
Health policy experts all agree something needs to be done to lower Medicare drug costs but none agree on how
Read MoreCalifornians can sock it to ‘greedy’ pharma. But will ballot vote bring down drug prices?
(By Ed Silverman for STAT) As Americans grapple with the rising cost of medicines, a contentious ballot measure1 in California
Read MoreMany Medicare Beneficiaries Not Reviewing Options
In a new Walgreens survey reveals even though drug costs are a top concern for Medicare beneficiaries, they are not
Read MoreGenetic testing fumbles, revealing ‘dark side’ of precision medicine
(By Sharon Begley for STAT) Enthusiasm for precision medicine1, from the White House2 down to everyday physicians, is at an all-time high.
Read MoreOpen Enrollment–Some Thoughts to Help You get Prepared
Now–right now–is the time to take stock in your situation while you still have time, and to get prepared to
Read More